Open AccessTicagrelor versus Genotype-Driven Antiplatelet Therapy for Secondary Prevention after Acute Coronary Syndrome: A Cost-Effectiveness Analysis
Author(s) -
Daniel J. Crespin,
Jerome J. Federspiel,
Andrea K. Biddle,
Daniel E Jonas,
Joseph S. Rossi
Publication year - 2011
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/qj8f-ph19
Subject(s) - ticagrelor , acute coronary syndrome , medicine , secondary prevention , cardiology , intensive care medicine , myocardial infarction